Response to Letters Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"

被引：0
|
作者：
Guazzi, Marco [1 ]
Vicenzi, Marco [1 ]
Arena, Ross [2 ]
Guazzi, Maurizio D. [3 ]
机构：
[1] Univ Milan, Cardiopulm Unit, Milan, Italy
[2] Univ New Mexico, Dept Phys Therapy, Albuquerque, NM 87131 USA
[3] Univ Milan, Dept Cardiol, Milan, Italy
来源：
CIRCULATION | 2012年 / 125卷 / 08期
关键词：
D O I：
10.1161/CIRCULATIONAHA.111.072090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E409 / E410
页数：2
相关论文
共 50 条
  • [41] Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study
    Evgeny Belyavskiy
    Artem Ovchinnikov
    Alexandra Potekhina
    Fail Ageev
    Frank Edelmann
    BMC Cardiovascular Disorders, 20
  • [42] The association between peak tricuspid regurgitation velocity and 1-year heart failure readmission in hospitalised patients with heart failure with preserved ejection fraction
    Wang, Tianbo
    Liu, Xiaohan
    Zhang, Yue
    Fang, Chenli
    Xu, Junbo
    ACTA CARDIOLOGICA, 2024,
  • [43] Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial
    Hussain, Imad
    Mohammed, Selma F.
    Forfia, Paul R.
    Lewis, Gregory D.
    Borlaug, Barry A.
    Gallup, Dianne S.
    Redfield, Margaret M.
    CIRCULATION-HEART FAILURE, 2016, 9 (04)
  • [44] H2FPEF score predicts 1-year rehospitalisation of patients with heart failure with preserved ejection fraction
    Tao, Yifei
    Wang, Wenjing
    Zhu, Jing
    You, Tao
    Li, Yi
    Zhou, Xiang
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1145) : 164 - 167
  • [45] Renal function deterioration and 1-year mortality in patients with acute decompensated heart failure and preserved or reduced ejection fraction
    Zairis, M.
    Patsourakos, A.
    Adamopoulou, E.
    Georgilas, A. Theodosis
    Benopoulos, A.
    Garefalakis, K.
    Smilakos, P.
    Makrygiannis, S.
    Katsaros, K.
    Foussas, S.
    EUROPEAN HEART JOURNAL, 2010, 31 : 574 - 574
  • [46] SGLT2 Inhibition Ameliorates Exercise-Induced Pulmonary Hypertension (EIPH) in Heart Failure with Preserved Ejection Fraction
    Satoh, T.
    Wang, L.
    Levine, A.
    Baust, J.
    Lai, Y.
    Wyman, S.
    Wu, Y.
    McTieman, C. F.
    Gladwin, M. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [47] Letter by Guazzi Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study"
    Guazzi, Marco
    CIRCULATION, 2015, 132 (13) : E160 - E160
  • [48] Response to the letter regarding the article 'Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction'
    Kresoja, Karl-Patrik
    Rommel, Karl-Philipp
    Thiele, Holger
    Lurz, Philipp
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04)
  • [49] Endothelin 1 Is Associated with Heart Failure Hospitalization and Long-Term Mortality in Patients with Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension
    Chowdhury, Mohammed Andaleeb
    Moukarbel, George V.
    Gupta, Rajesh
    Frank, Stephanie Marie
    Anderson, Ann M.
    Liu, Lijun C.
    Khouri, Samer J.
    CARDIOLOGY, 2019, 143 (3-4) : 124 - 133
  • [50] Phosphodiesterase 5 Inhibitor Therapy Improves Clinical Parameters in Patients With Heart Failure With Preserved Ejection Fraction and Combined Post- and Pre-capillary Pulmonary Hypertension
    Kramer, Tilmann T.
    Orlova, Kristina
    Gerhardt, Felix
    Dumitrescu, Daniel
    ten-Freyhaus, Henrik
    Baldus, Stephan
    Rosenkranz, Stephan
    CIRCULATION, 2017, 136
12345